|
| Press Releases |
|
 |
|
| Friday, May 13, 2022 |
|
|
祝賀！國際頂級醫學期刊《自然-醫學》同時發表兩篇關於華領醫藥全球首創糖尿病新藥多格列艾汀的III期研究結果的同行評議論文 |
| 華領醫藥(“公司”，香港聯交所主機板股份代號：2552.HK)今日宣佈，國際頂級醫學刊物《自然-醫學》（Nature Medicine）雜誌同時線上發表了兩篇公司全球首創糖尿病新藥葡萄糖激酶啟動劑（GKA）多格列艾汀（dorzagliatin）的III期註冊臨床研究結果的同行評議論文。 more info >> |
|
|
祝贺！国际顶级医学期刊《自然-医学》同时发表两篇关于华领医药全球首创糖尿病新药多格列艾汀的III期研究结果的同行评议论文 |
| 华领医药(“公司”，香港联交所主板股份代号：2552.HK)今日宣布，国际顶级医学刊物《自然-医学》（Nature Medicine）杂志同时在线发表了两篇公司全球首创糖尿病新药葡萄糖激酶激活剂（GKA）多格列艾汀（dorzagliatin）的III期注册临床研究结果的同行评议论文。 more info >> |
|
| Thursday, June 18, 2020 |
|
|
華領醫藥成功完成Dorzagliatin單藥治療III期臨床試驗SEED研究（HMM0301） |
| 華領醫藥（“公司”，香港聯交所股份代號：2552.HK），一家針對全球糖尿病患者尚未滿足的臨床需求研發全球原創新藥的生物技術公司，今天宣佈了dorzagliatin的首個III期臨床試驗，SEED（也稱為HMM0301）的結果。 more info >> |
|
| Friday, May 13, 2022 |
|
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine |
| Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin more info >> |
|
| Thursday, March 17, 2022 |
|
|
华领医药公布2021年全年业绩 |
| 华领医药（「公司」，香港联交所股份代号：2552），今天宣布公司及其附属公司截至2021年12月31日止，经审核的全年业绩（「报告期」）。 more info >> |
|
|
華領醫藥公佈2021年全年業績 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552），今天宣佈公司及其附屬公司截至2021年12月31日止，經審核的全年業績（「報告期」）。 more info >> |
|
|
Hua Medicine Announces 2021 Annual Results |
| Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period"). The Reporting Period witnessed significant milestones in the commercialization process of dorzagliatin. more info >> |
|
| Sunday, September 26, 2021 |
|
|
研究者公布有关多格列艾汀糖尿病缓解的重要研究 |
| 华领医药（「公司」，香港联交所股份代号：2552.HK）今天宣布，在苏州举办的第六届中国医药创新与投资大会（The China BioMed Innovation and Investment Conference，以下简称CBIIC）上，中华医学会糖尿病学分会常委、南京市第一医院内分泌科主任马建华教授作为主要研究者之一，公布了一项名为DREAM的临床研究结果，研究显示华领医药全球首创新药葡萄糖激酶激活剂多格列艾汀(dorzagliatin) 有望在糖尿病缓解方面取得进展。 more info >> |
|
|
研究者公佈有關多格列艾汀糖尿病緩解的重要研究 |
| more info >> |
|
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
| Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
EdgePoint Towers Appoints Ravin Vickneswaran as Chief Operating Officer
Apr 7, 2025 03:06 HKT/SGT
|
|
|
2024年華泰證券營收創新高 累計分紅46.94億元
Apr 6, 2025 22:30 HKT/SGT
|
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
Apr 6, 2025 20:30 HKT/SGT
|
|
|
《周遊記3》開播 背後「隱藏玩家」巨星傳奇再造頂流綜藝IP
Apr 6, 2025 19:45 HKT/SGT
|
|
|
雲康集團2024年醫聯體共建業務及特檢項目收益佔比持續增長
Apr 6, 2025 18:27 HKT/SGT
|
|
|
Smart Lighting Expo and Spring Lighting Fair open today
Apr 6, 2025 16:55 HKT/SGT
|
|
|
ForexRova Debuts at International Forex Conference, Promises Smarter Gold Trading Solutions
Apr 5, 2025 19:00: JST
|
|
|
ForexRova Debuts at International Forex Conference, Promises Smarter Gold Trading Solutions
Apr 5, 2025 18:00 HKT/SGT
|
|
|
Connect Marketplace Hong Kong 2025 Concludes, Successfully Ushering in a New Era for MICE in the City
Apr 4, 2025 0:00 JST
|
|
|
JF SmartInvest Holdings Ltd Announces 2024 Annual Results
Apr 4, 2025 22:48 HKT/SGT
|
|
|
The India Market Entry Dilemma: What's Holding Manufacturers Back
Apr 4, 2025 22:08 HKT/SGT
|
|
|
3rd Future Cross Border Payments Summit, Dubai 2025: Trends Shaping the Future of Payments
Apr 4, 2025 21:15 HKT/SGT
|
|
|
CISO Indonesia 2025: Elevating Cybersecurity Strategies for a Resilient Digital Future
Apr 4, 2025 20:50 HKT/SGT
|
|
|
analytica Vietnam 2025 Opens Tomorrow: The Leading Laboratory Exhibition Returns to Vietnam
Apr 4, 2025 20:40 HKT/SGT
|
|
|
Kirin and Hitachi begin joint research on the creation of forest-based carbon credits
Apr 4, 2025 15:56 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
